Happy Friday.
It’s the start of Labor Day weekend— summer’s last hurrah here in the United States.
I was at the QFC grocery store, and thought: ‘Let me check with the pharmacy to see when they will have the new Covid vaccine’.
Well, it had arrived, so there I was 5 minutes later, inside the little vaccination room, rolling up my sleeve for my shot. Done.
This mRNA COVID-19 vaccine (2024-2025 formula) includes a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.
(As of August 20, 2024, the SARS-CoV-2 Omicron variants KP.2, KP.2.3, KP.3 and KP.3.1.1, as well as LB.1, have high prevalence in the United States.)
The first phase of human trials studying a possible COVID-19 vaccine as an intranasal spray has opened, the National Institutes of Health (NIH) announced recently.
[Graphic from https://products.modernatx.com/spikevax]